Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway
IUBMB Life · 2024-03 · 76 (3) · 140-160
DOI: 10.1002/iub.2785 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, online erschienen am 20.09.2023. Verfasst von Weiye Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, School of Medicine, South China University of Technology, Guangzhou, China. Hauptthemen laut MEDLINE: Glioblastoma, Glioma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The molecular mechanisms of glioblastoma (GBM) are unclear, and the prognosis is poor. Spinster homolog 2 (SPNS2) is reportedly involved in pathological processes such as immune response, vascular development, and cancer. However, the biological function and molecular role of SPNS2 in GBM are unclear. SPNS2 is aberrantly low expressed in glioma. Survival curves, risk scores, prognostic nomograms, and univariate and multifactorial Cox regression analyses showed that SPNS2 is an independent prognostic indicator significantly associated with glioma progression and prognosis. Cell function assays and in vivo xenograft transplantation were performed that downregulation of SPNS2 promoted GBM cell growth, migration, invasion, epithelial–mesenchymal transition (EMT), anti‐apoptosis, drug resistance, and stemness, while overexpression of SPNS2 had the opposite effect. Meanwhile, the functional enrichment and signaling pathways of SPNS2 in the Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), and RNA sequencing were analyzed by Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene set enrichment analysis (GSEA). The above results were related to the inhibition of the PTEN/PI3K/AKT pathway by SPNS2. In addition, we predicted that SPNS2 is closely associated with immune infiltration in the tumor microenvironment by four immune algorithms, ESTIMATE, TIMER, CIBERSORT, and QUANTISEQ. In particular, SPNS2 was negatively correlated with the infiltration of most immune cells, immunomodulators, and chemokines. Finally, single‐cell sequencing analysis also revealed that SPNS2 was remarkably correlated with macrophages, and downregulation of SPNS2 promotes the expression of M2‐like macrophages. This study provides new evidence that SPNS2 inhibits malignant progression, stemness, and immune infiltration of GBM cells through PTEN/PI3K/AKT pathway. SPNS2 may become a new diagnostic indicator and potential immunotherapeutic target for glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, School of Medicine, South China University of Technology, Guangzhou, China.
- Center for Pancreatic Cancer Research, School of Medicine, South China University of Technology, Guangzhou, China.
- CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biom…
- Department of Pathology, Affiliated Hospital of Qingdao University, Qingdao, China.
ORCID-Profile: Weiye Liang, Jian Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liang, W., Liu, M., Su, Y., Wen, Y., Wang, L., Shan, J., Zhao, J., Xie, K., & Wang, J. (2024). Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway. IUBMB Life, 76(3), 140-160. https://doi.org/10.1002/iub.2785
Vancouver
Liang W, Liu M, Su Y, Wen Y, Wang L, Shan J, et al. Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway. IUBMB Life. 2024;76(3):140-160. doi:10.1002/iub.2785
BibTeX
@article{Liang2024,
author = {Liang, Weiye and Liu, Mingkai and Su, Yuling and Wen, Yulin and Wang, Lili and Shan, Jiajie and Zhao, Jie and Xie, Keping and Wang, Jian},
title = {Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway},
journal = {IUBMB Life},
year = {2024},
volume = {76},
number = {3},
pages = {140--160},
doi = {10.1002/iub.2785}
}
EUVIMED